Association Between Cannabis Use and Risk for Diabetic Ketoacidosis in Adults With Type 1 Diabetes
Open accessThe DOI matches its Crossref record.
Abstract
ket.A biosimilar of Sanofi's popular insulin Lantus was approved for use in the European Union in 2014 but was initially delayed for 2 more years by a lawsuit in the United States.6 Now that the biosimilar product, Basaglar, has finally hit the market, its price is only minimally lower than the original brand.7 The same insulin pen that retails for $140 in the United States costs less than $15 in Germany and Canada.8 The US insurance system-private and public-does not cut people with chronic disease a break but instead tends to penalize them.People with type 1 diabetes are people who drew a short straw in the disease lottery.Most other developed countries have concluded that their citizens should therefore not be subject to copays or high deductibles."If you have a chronic disease, you shouldn't be burdened by the cost," York F. Zöllner, a professor of health economics at Hamburg University of Applied Sciences, told me in an interview for the New York Times before explaining the German approach, in which out-of-pocket contributions for insulin are less than $100 per year.9 Until very recently, the disease foundations (JDRF and the American Diabetes Association among them), as well as many diabetes patient groups, did not protest much as the prices rose, in part likely because so many receive funding from pharmaceutical companies.Extreme prices can lead to extreme solutions.A 29-year-old student in Missouri with diabetes whom I interviewed for my book 10 told me that she would only consider doctoral programs outside of the United States."My one goal in life has been to move to Europe so I don't have to pay these staggering prices just to survive," she said.But others-that 25%-will quietly skimp on their insulin, taking less than they need but more, perhaps, than they can really afford.Some of them will die.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Eichorst, B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s005 · Cited by 305
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Beverly, E. A., Bruemmer, D., Collins, B. S., Darville, A., Ekhlaspour, L., Hassanein, M., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s005 · Cited by 285
Alcohol and illicit drug use in people with diabetes
Pastor, A., Conn, J., MacIsaac, R. J., & Bonomo, Y. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30410-3 · Cited by 53
Kinney, G. L., Akturk, H. K., Taylor, D. D., Foster, N. C., & Shah, V. N. (2020) · Diabetes Care · doi:10.2337/dc19-0365 · Cited by 51
Self-citationEffects of Cannabis on Cardiovascular System: The Good, the Bad, and the Many Unknowns
Dabiri, A. E., & Kassab, G. S. (2021) · Medical Cannabis and Cannabinoids · doi:10.1159/000519775 · Cited by 21
Metadata
- Authors
- Akturk, H. K., Taylor, D. D., Camsari, U. M., Rewers, A., Kinney, G. L., & Shah, V. N.
- Venue
- JAMA Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2019-01-01
- Volume
- 179
- Issue
- 1
- Pages
- 115
- ISSN
- 2168-6106 (ISSN-L)
- OpenAlex
- W2899972966
- Cited by
- 49
- References
- 0
- FWCI
- 4.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Association Between Cannabis Use and Risk for Diabetic Ketoacidosis in Adults With Type 1 Diabetes. https://app.cochat.ai/papers/10.1001/jamainternmed.2018.5142
- The paper
- Akturk, H. K., Taylor, D. D., Camsari, U. M., Rewers, A., Kinney, G. L., & Shah, V. N. (2019). Association Between Cannabis Use and Risk for Diabetic Ketoacidosis in Adults With Type 1 Diabetes. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2018.5142
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.